| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8739845 | Journal of Clinical Virology | 2018 | 4 Pages |
Abstract
When compared to the use of HCVGT II alone, HCVGT II/Plus significantly reduced the frequency of GT 1 without ST results observed in a large reference laboratory, while also enabling the identification of HCV GT 6.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Chao He, Jeffrey J. Germer, Elizabeth R. Ptacek, Carl E. Bommersbach, P.Shawn Mitchell, Joseph D.C. Yao,